Login to Your Account



Renexxion advances former Aryx GI drug under new FDA guidance

By Michael Fitzhugh
Staff Writer

Wednesday, November 16, 2016

A drug for gastrointestinal troubles shelved during Aryx Therapeutics Inc.'s 2011 demise is back in action at Renexxion LLC propelled by new FDA guidance.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription